Aera Therapeutics

Aera Therapeutics is a biotechnology company that leverages its proprietary Protein Nanoparticle (PNP) delivery platform to unlock the full potential of genetic medicines. Aera's platform, based on endogenous human proteins, is under development to address the limitations of current delivery technologies and expand the scope of genetic medicines to different tissues and applications, benefiting patients across more disease areas. Aera’s licensed technology also includes a therapeutic enzyme platform focused on discovering novel, compact, and programmable gene-editing enzymes.